JOEL MANILAY: Open Payments
NPI 1568584662 · PASADENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,298 in 40 payments from 10 companies in 2025. Trend: 2023 $653 · 2024 $675 · 2025 $1,298
Food & beverage: $1,298
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 14 | $342 |
| Inspire Medical Systems, Inc. | 4 | $251 |
| Regeneron Healthcare Solutions, Inc. | 6 | $216 |
| GENZYME CORPORATION | 6 | $214 |
| Smith+Nephew, Inc. | 2 | $60 |
| PolyNovo North America LLC | 1 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| Integra LifeSciences Corporation | 2 | $42 |
| Optinose US, Inc. | 2 | $41 |
| Lilly USA, LLC | 1 | $31 |
Products named: DUPIXENT, NUCALA, INSPIRE, TULA, NOVOSORB BTM, TEZSPIRE, ACCLARENT AERA, Xhance.
Industry payments across CA — which companies pay providers there.
